ArticleACS infectious diseases2022

Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses.

Brendan T Freitas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.